Literature DB >> 3245800

Immune status in patients with Menière's disease.

K L Evans1, D L Baldwin, D Bainbridge, A W Morrison.   

Abstract

Sera of 164 patients with classical Meniere's disease were screened for autoantibodies, immune complexes and HLA status. Increased thyroid microsomal antibodies were significant in those patients in the 40- to 60-year age range. Raised IgM complexes and C1q component of complement were significant in all age groups. Low levels of IgA complexes were a consistent finding and were significantly lower in the HLA Cw7 group. Patients with migraine had no increased incidence of immune disturbances.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3245800     DOI: 10.1007/bf00464632

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  20 in total

1.  Antinuclear factors in sera from healthy blood donors.

Authors:  A Wiik
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-06

2.  Plasma exchange in the treatment of immune complex-associated sensorineural deafness.

Authors:  G B Brookes; A C Newland
Journal:  J Laryngol Otol       Date:  1986-01       Impact factor: 1.469

3.  Immunology of the inner ear: response of the inner ear to antigen challenge.

Authors:  J P Harris
Journal:  Otolaryngol Head Neck Surg       Date:  1983-02       Impact factor: 3.497

4.  Type II collagen autoimmunity in otosclerosis and Meniere's Disease.

Authors:  T J Yoo; J M Stuart; A H Kang; A S Townes; K Tomoda; S Dixit
Journal:  Science       Date:  1982-09-17       Impact factor: 47.728

5.  Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac.

Authors:  H Rask-Andersen; J Stahle
Journal:  Acta Otolaryngol       Date:  1980 Mar-Apr       Impact factor: 1.494

6.  Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders.

Authors:  W Arnold; R Pfaltz; H J Altermatt
Journal:  Acta Otolaryngol       Date:  1985 Mar-Apr       Impact factor: 1.494

7.  Immunological disorders and auditory lesions.

Authors:  S D Stephens; L Luxon; R Hinchcliffe
Journal:  Audiology       Date:  1982

8.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

9.  Autoimmune reactivity in Ménière's disease: a preliminary report.

Authors:  G B Hughes; S E Kinney; B P Barna; L H Calabrese
Journal:  Laryngoscope       Date:  1983-04       Impact factor: 3.325

10.  Autoimmune reactivity in Cogan's syndrome: a preliminary report.

Authors:  G B Hughes; S E Kinney; B P Barna; R L Tomsak; L H Calabrese
Journal:  Otolaryngol Head Neck Surg       Date:  1983-02       Impact factor: 3.497

View more
  7 in total

Review 1.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

2.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

Review 3.  Menière's disease: pathophysiology and treatment.

Authors:  H Thai-Van; M J Bounaix; B Fraysse
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

5.  Possible association between thyroid autoimmunity and Menière's disease.

Authors:  B Fattori; A Nacci; A Dardano; I Dallan; M Grosso; C Traino; V Mancini; F Ursino; F Monzani
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

6.  Detection of inner ear disease autoantibodies by immunoblotting.

Authors:  M Y Cao; M Gersdorff; N Deggouj; M Warny; J P Tomasi
Journal:  Mol Cell Biochem       Date:  1995-05-24       Impact factor: 3.396

Review 7.  Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.

Authors:  Laura Girasoli; Diego Cazzador; Roberto Padoan; Ennio Nardello; Mara Felicetti; Elisabetta Zanoletti; Franco Schiavon; Roberto Bovo
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.